Tag: genotyping market

Uncover key drivers, emerging technologies, and competitive movements shaping the genotyping market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Genotyping Market in 2026, and what figure is it projected to hit by 2030?

The genotyping market has experienced rapid expansion in its size over recent years. Projections indicate it will expand from $26.55 billion in 2025 to reach $31.26 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 17.7%. Historically, this growth can be ascribed to several factors, including advancements in molecular biology, pioneering genetic variation studies, the proliferation of diagnostic laboratories, the embrace of academic research, and the creation of microarray technologies.

The genotyping market is poised for substantial expansion over the next few years, with its size expected to reach $60.54 billion by 2030, growing at a compound annual growth rate (CAGR) of 18.0%. This anticipated growth throughout the forecast period can be attributed to several factors, including the increasing reach of precision medicine, advancements in crop genetics research, a decrease in genotyping costs, greater biopharma investment, and its incorporation into clinical diagnostics. Prominent trends for the forecast period include the expanding application of genotyping in personalized medicine, its broader use in agricultural biotechnology, a rise in the adoption of high-throughput genotyping platforms, an elevated demand for pharmacogenomics applications, and the integration of bioinformatics within genotyping workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

Which Drivers Are Affecting Market Participation In The Genotyping Market?

The increasing need for genetic testing is anticipated to boost the expansion of the genotyping market in the future. Genetic testing, alternatively referred to as DNA testing or molecular testing, entails examining an individual’s DNA (deoxyribonucleic acid) to detect variations, mutations, or changes within their genetic code. Within genetic testing, genotyping serves to offer precise data regarding an individual’s genetic variations or distinctions in their DNA. As an illustration, in February 2025, the NHS England, a UK government healthcare agency, reported that its NHS Genomic Medicine Service provided more than 810,000 genomic tests for patients throughout England during 2024. This figure has shown a consistent annual rise since the establishment of the NHS Genomic Medicine Service, demonstrating an 8% increase when compared to 2023. Consequently, the heightened demand for genetic testing is fueling the expansion of the genotyping market.

What Segment Classifications Make Up The Genotyping Market?

The genotyping market covered in this report is segmented –

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service

2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies

3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications

4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users

Subsegments:

1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms

2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits

3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions

4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

What Trends Are Driving The Growth Trajectory Of The Genotyping Market?

Major companies operating in the genotyping market are primarily focusing their efforts on creating innovative solutions, including high-coverage whole genome sequencing. High-coverage whole genome sequencing (WGS) is characterized as a comprehensive and advanced genetic sequencing method that involves analyzing an individual’s entire genome with a high degree of coverage. For instance, in September 2023, CD Genomics, a U.S.-based provider of genomics, transcriptomics, and bioinformatics services, launched its Genotyping by Sequencing (GBS) service. This service utilizes next-generation sequencing alongside restriction enzyme digestion to deliver high-throughput, cost-effective genome-wide SNP genotyping for extensive sample sets. CD Genomics’ Genotyping by Sequencing (GBS) launch provides high-throughput, cost-efficient variant detection, supported by streamlined library preparation, to expedite genomic discovery. Furthermore, the platform offers dense genome-wide marker coverage and scalable multiplexing, allowing for rapid and accurate genotyping across diverse species.

Which Key Players Are Driving Competition In The Genotyping Market?

Major companies operating in the genotyping market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Which Region Currently Holds The Largest Share Of The Genotyping Market?

North America was the largest region in genotyping market in 2025. The regions covered in the genotyping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genotyping Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

Browse Through More Reports Similar to the Global Genotyping Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genotyping Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Single Nucleotide Polymorphism Snp Genotyping Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Genotyping Industry By 2029?

In recent times, there has been a formidable surge in the size of the genotyping market. The market is predicted to proliferate from $23.04 billion in 2024 to $26.55 billion by 2025, with a compound annual growth rate (CAGR) of 15.3%. The phenomenal growth in the historic period results from government actions and funding, a swift drop in genotyping expenses, the broadening of biobanks and genetic databases, escalating rates of genetic disorders, along with advancements in pharmacogenomics and drug development.

In the coming years, an accelerated expansion is anticipated in the genotyping market. By 2029, its valuation is predicted to reach $51.22 billion, with a compound annual growth rate (CAGR) of 17.8%. The upsurge during the forecast period can be linked to its increasingly widespread use in clinical diagnostics, escalating needs for personalized medicine, enhanced research and development initiatives, and widening applications in both agriculture and livestock. The forecast period’s significant trends encompass escalated interest in pharmacogenomics, advancements made in next-generation sequencing (ngs), a wider spread in precision medicine initiatives, increasing interest in direct-to-consumer (dtc) genetic testing, and an emphasis on cancer genomics and tailored therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

Which Growth Drivers Are Shaping The Genotyping Market Outlook?

The upward trend in cancer and genetic disorder rates is predicted to stimulate the expansion of the genotyping market in the future. Cancer encompasses a wide range of diseases that can originate from almost any organ or tissue in the body, and genetic disorders are conditions largely or entirely caused by anomalies in the standard DNA sequence. Genotyping allows researchers to explore genetic differences such as single nucleotide variations, copy number variations, and significant alterations in DNA structure. Genotyping, or genetic testing, seeks specific gene mutations that could increase an individual’s risk of developing specific cancers. For example, the World Health Organization, a Switzerland-based specialized institution committed to universal public health, reported in February 2024 that around 20 million new cancer cases occurred in 2022, leading to 9.7 million deaths. At the same time, about 53.5 million people were alive five years after a cancer diagnosis. Moreover, according to UK charity Gene People UK, it was projected in February 2023 that 1 in 25 children has a genetic disorder. This suggests that annually, 30,000 infants and children are newly diagnosed with a genetic disorder in the UK, and more than 2.4 million children and adults have a genetic condition. Thus, the growing occurrence of cancer and genetic disorders is spurring the expansion of the genotyping market.

How Is The Global Genotyping Market Broken Down By Segment?

The genotypingmarket covered in this report is segmented –

1) By Product And Services: Instruments; Reagents And Kits; Bioinformatics; Genotyping Service

2) By Technology: Microarrays; Capillary Electrophoresis; Sequencing; Polymerase Chain Reaction; Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry; Other Technologies

3) By Application: Pharmacogenomics; Diagnostics And Personalized Medicine; Animal Genetics; Agricultural Biotechnology; Other Applications

4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Diagnostics And Research Laboratories; Academic Institutes; Other End-Users

Subsegments:

1) By Instruments: Sequencers; PCR Machines; Microarrays; Genotyping Platforms

2) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Next-Generation Sequencing (NGS) Kits

3) By Bioinformatics: Data Analysis Software; Genomic Data Management Tools; Cloud-based Solutions

4) By Genotyping Services: Contract Research Organizations (CRO) Services; Custom Genotyping Services; Sample Preparation Services

Which Market Trends Are Expected To Define The Future Of The Genotyping Market?

The introduction of unique products is a prominent trend that is becoming increasingly popular in the genotyping market. Organizations in this industry are leveraging pioneering solutions to maintain their market stance. For instance, in May 2022, Neogen, an American food safety organization, in partnership with Gencove Inc., an American Genome discovery sequencing platform provider, unveiled InfiniSEEK. This innovative, cost-effective solution designed for whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis is a first for cattle breeders. InfiniSEEK enables the industry to efficiently handle over 400 bovine genetic traits and conditions, discover new factors influencing favorable phenotypes, and minimize selection bias by sequencing a larger or entire population. With the introduction of this unique service, customers now have a cost-effective, data-rich approach for profiling cattle globally, merging genome-wide sequencing data, specific genetic characteristics, and parentage markers.

Who Are The Primary Market Leaders In The Genotyping Market?

Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Genotyping Market?

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

Browse Through More Reports Similar to the Global Genotyping Market 2025, By The Business Research Company

Train And Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/train-and-components-global-market-report

Rail Asset Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rail-asset-management-global-market-report

Powertrain And Powertrain Parts Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/powertrain-and-powertrain-parts-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Genotyping Market Covering 2025–2034?

The genotyping market size has experienced rapid growth in recent years. Its value is projected to expand from $23.04 billion in 2024 to $26.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.3%. The historical expansion of this market can be attributed to various factors such as government initiatives and funding, a rapid decline in genotyping costs, the expansion of biobanks and genetic databases, an increasing prevalence of genetic disorders, and advancements in pharmacogenomics and drug development.

The genotyping market is projected for significant expansion over the coming years. By 2029, it is forecast to reach $51.22 billion, exhibiting a compound annual growth rate (CAGR) of 17.8%. This growth during the forecast period can be attributed to factors such as increased adoption in clinical diagnostics, the growing demand for personalized medicine, a rise in research and development initiatives, and its expanding application in agriculture and livestock. Major trends anticipated for the forecast period include the rise in demand for pharmacogenomics, advancements in next-generation sequencing (ngs), the expansion in precision medicine initiatives, the growth in direct-to-consumer (dtc) genetic testing, and a focus on cancer genomics and personalized therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

Which Industry Drivers Are Expected To Accelerate The Genotyping Market From 2025 To 2029?

The growing incidence of cancer and genetic conditions is anticipated to drive the expansion of the genotyping market in the future. Cancer encompasses a wide range of diseases that can originate in almost any bodily organ or tissue, whereas genetic disorders are conditions caused, in whole or in part, by an unusual DNA sequence. Genotyping allows researchers to examine genetic variations, including single nucleotide variations, copy number variations, and significant structural alterations in DNA. This genetic testing method, known as genotyping, identifies particular gene mutations or changes that could increase an individual’s susceptibility to developing specific cancers. For example, data from the World Health Organization, a Switzerland-based international public health agency, indicated in February 2024 that around 20 million new cancer cases were recorded in 2022, leading to 9.7 million fatalities. Concurrently, an estimated 53.5 million people were living five years post-cancer diagnosis. Moreover, figures from Gene People UK, a UK-based registered charity, revealed in February 2023 that approximately 1 in every 25 children lives with a hereditary condition. This translates to 30,000 infants and children receiving new diagnoses yearly in the UK, with over 2.4 million children and adults affected by a genetic disorder. Consequently, the increasing prevalence of cancer and genetic disorders is fueling the expansion of the genotyping market.

What Are The Major Segments Identified In The Genotyping Market?

The genotypingmarket covered in this report is segmented –

1) By Product And Services: Instruments; Reagents And Kits; Bioinformatics; Genotyping Service

2) By Technology: Microarrays; Capillary Electrophoresis; Sequencing; Polymerase Chain Reaction; Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry; Other Technologies

3) By Application: Pharmacogenomics; Diagnostics And Personalized Medicine; Animal Genetics; Agricultural Biotechnology; Other Applications

4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Diagnostics And Research Laboratories; Academic Institutes; Other End-Users

Subsegments:

1) By Instruments: Sequencers; PCR Machines; Microarrays; Genotyping Platforms

2) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Next-Generation Sequencing (NGS) Kits

3) By Bioinformatics: Data Analysis Software; Genomic Data Management Tools; Cloud-based Solutions

4) By Genotyping Services: Contract Research Organizations (CRO) Services; Custom Genotyping Services; Sample Preparation Services

Which Market Trends Are Creating New Opportunities In The Genotyping Industry?

Product innovation represents a significant trend gaining traction in the genotyping market. Companies operating within this market are adopting advanced solutions to secure their competitive standing. For example, in May 2022, Neogen, a US-based food safety company, and Gencove Inc., a US-based firm specializing in sequencing platforms for genome discovery, introduced InfiniSEEK. This innovative and cost-effective solution facilitates whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis. It stands as the premier whole-genome and genotyping sequencing solution specifically designed for cattle breeders. Through InfiniSEEK, the industry now possesses a platform capable of reliably managing over 400 bovine genetic characteristics and conditions, uncovering new variables affecting desired phenotypes, and mitigating selection bias by sequencing larger portions or entire populations. The launch of this unique service offers consumers a data-rich, economical approach to profile cattle globally by integrating genome-wide sequencing data, specific genetic traits, and parentage markers.

Which Key Players Are Driving Competition In The Genotyping Market?

Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

How Is Genotyping Market Demand Varying Across Different Regions?

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genotyping Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

Browse Through More Reports Similar to the Global Genotyping Market 2025, By The Business Research Company

Train And Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/train-and-components-global-market-report

Rail Asset Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rail-asset-management-global-market-report

Powertrain And Powertrain Parts Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/powertrain-and-powertrain-parts-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Genotyping Market Growth in 2025?

The genotyping market has seen a substantial growth in the recent years. It is projected to increase from $23.04 billion in 2024 to $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The impressive growth experienced during the historical period can be owed to factors such as government schemes and funding, drastic reduction in genotyping costs, the proliferation of biobanks and genetic databases, rising incidence of genetic disorders, and advancements in pharmacogenomics and drug development.

What Is the Forecast for the Genotyping Market Size Through 2029?

Projections indicate swift expansion in the genotyping market in the upcoming years, with its value expected to rise to $51.43 billion in 2029, by growing at a compound annual growth rate (CAGR) of 17.9%. The forecasted increase in this period is tied to the wider acceptance and application in clinical diagnostics, increasing appeal of personalized medicine, an uptick in research and development activities, and a wider application scope in agriculture and livestock. The speculated trends in this period involve growing appeal for pharmacogenomics, advancements in next-generation sequencing (NGS), development in precision medicine initiatives, surge in direct-to-consumer (DTC) genetic testing, and heightened interest in cancer genomics and customized therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

What are the Key Market Players in Genotyping Market and How They’re Evolving?

Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

What Are the Primary Growth Drivers in the Genotyping Market?

An increase in cancer and genetic disorders is anticipated to fuel the genotyping market’s expansion. A diverse array of diseases that can originate in just about any part of the human body is what comprises cancer, while genetic disorders are illnesses in whole or in part caused by an alteration in the typical DNA sequence. Genotyping is a tool that experts can utilize to scrutinize DNA abnormalities like single nucleotide alterations, copy number deviations, and significant alterations in the DNA’s structure. Genotyping or genetic testing can help identify certain genetic mutations that might boost a person’s vulnerability to specific cancers. For instance, according to the World Health Organization, a public health agency based in Switzerland, in 2022, almost 20 million new cancer cases were documented leading to 9.7 million deaths. At the same time, around 53.5 million people survived for five years post their cancer diagnosis. In addition, according to Gene People UK, a registered charity in the UK, it’s estimated that 1 out of every 25 children suffers from a genetic disease. This denotes that approximately 30,000 infants and children are being newly diagnosed in the UK each year, and over 2.4 million children and adults suffer from a genetic disorder. Consequently, the growing ubiquity of cancer and genetic disorders is propelling the advancement of the genotyping market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

What Are the Leading Segments in the Global Genotyping Industry?

The genotyping market covered in this report is segmented –

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service

2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies

3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications

4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users

Subsegments:

1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms

2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits

3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions

4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

What Are the Key Market Trends in the Genotyping Industry?

The advent of product innovation is a predominant trend in the genotyping market. To remain competitive, companies in this sector are resorting to ingenious solutions. Neogen, an American food safety company, in collaboration with Gencove Inc., another American company specializing in a platform for genomic discovery, launched InfiniSEEK in May 2022. This is an innovative and economical solution for full genome sequencing and targeted Single Nucleotide Polymorphism (SNP) analysis. It’s the first complete genome and genotyping sequencing solution tailored specifically for cattle breeders. InfiniSEEK provides a reliable platform to manage over 400 bovine genetic traits and conditions, uncover new variables that influence desirable traits, and reduce selection bias by sequencing a larger or full population. This new service offers consumers an abundant and affordable data source for global cattle profiling, merging genome-wide sequencing data, specific genetic attributes, and markers of parentage.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

What Is the Regional Outlook for the Genotyping Market?

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059

This Report Delivers Insight On:

1. How big is the genotyping market, and how is it changing globally?

2. Who are the major companies in the genotyping market, and how are they performing?

3. What are the key opportunities and risks in the genotyping market right now?

4. Which products or customer segments are growing the most in the genotyping market?

5. What factors are helping or slowing down the growth of the genotyping market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the genotyping industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Genotyping Market From 2025 To 2029?

The genotyping market has seen a substantial growth in the recent years. It is projected to increase from $23.04 billion in 2024 to $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The impressive growth experienced during the historical period can be owed to factors such as government schemes and funding, drastic reduction in genotyping costs, the proliferation of biobanks and genetic databases, rising incidence of genetic disorders, and advancements in pharmacogenomics and drug development.

Projections indicate swift expansion in the genotyping market in the upcoming years, with its value expected to rise to $51.43 billion in 2029, by growing at a compound annual growth rate (CAGR) of 17.9%. The forecasted increase in this period is tied to the wider acceptance and application in clinical diagnostics, increasing appeal of personalized medicine, an uptick in research and development activities, and a wider application scope in agriculture and livestock. The speculated trends in this period involve growing appeal for pharmacogenomics, advancements in next-generation sequencing (NGS), development in precision medicine initiatives, surge in direct-to-consumer (DTC) genetic testing, and heightened interest in cancer genomics and customized therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

Which Factors and External Forces Are Driving Demand in the Genotyping Market?

An increase in cancer and genetic disorders is anticipated to fuel the genotyping market’s expansion. A diverse array of diseases that can originate in just about any part of the human body is what comprises cancer, while genetic disorders are illnesses in whole or in part caused by an alteration in the typical DNA sequence. Genotyping is a tool that experts can utilize to scrutinize DNA abnormalities like single nucleotide alterations, copy number deviations, and significant alterations in the DNA’s structure. Genotyping or genetic testing can help identify certain genetic mutations that might boost a person’s vulnerability to specific cancers. For instance, according to the World Health Organization, a public health agency based in Switzerland, in 2022, almost 20 million new cancer cases were documented leading to 9.7 million deaths. At the same time, around 53.5 million people survived for five years post their cancer diagnosis. In addition, according to Gene People UK, a registered charity in the UK, it’s estimated that 1 out of every 25 children suffers from a genetic disease. This denotes that approximately 30,000 infants and children are being newly diagnosed in the UK each year, and over 2.4 million children and adults suffer from a genetic disorder. Consequently, the growing ubiquity of cancer and genetic disorders is propelling the advancement of the genotyping market.

Which Segments in the Genotyping Offer the Most Growth?

The genotyping market covered in this report is segmented –

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service

2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies

3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications

4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users

Subsegments:

1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms

2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits

3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions

4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Genotyping Market?# Market?

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theGenotyping Market’s Growth?

The advent of product innovation is a predominant trend in the genotyping market. To remain competitive, companies in this sector are resorting to ingenious solutions. Neogen, an American food safety company, in collaboration with Gencove Inc., another American company specializing in a platform for genomic discovery, launched InfiniSEEK in May 2022. This is an innovative and economical solution for full genome sequencing and targeted Single Nucleotide Polymorphism (SNP) analysis. It’s the first complete genome and genotyping sequencing solution tailored specifically for cattle breeders. InfiniSEEK provides a reliable platform to manage over 400 bovine genetic traits and conditions, uncover new variables that influence desirable traits, and reduce selection bias by sequencing a larger or full population. This new service offers consumers an abundant and affordable data source for global cattle profiling, merging genome-wide sequencing data, specific genetic attributes, and markers of parentage.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

What Are the Key Elements That Define the Genotyping Market?

Genotyping is a lab procedure examining a person’s germline DNA for nucleotides or bases to see if certain variations are present. Researchers can explore genetic variants such as single nucleotide variations, copy number variations, and substantial structural alterations in DNA using genotyping. It is used in various fields, including agriculture, medicine, and basic science.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model